TD Asset Management
GBIO

TD Asset Management’s Generation Bio GBIO Stock Holding History

TD Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,708
Closed -$152K – 1256
2025
Q4 		$152K Hold
26,708
– – ﹤0.01% 1227
2025
Q3 		$163K Sell
26,708
-7,361
-22% -$38.1K ﹤0.01% 1228
2025
Q2 		$109K Hold
34,069
– – ﹤0.01% 1187
2025
Q1 		$138K Hold
34,069
– – ﹤0.01% 1201
2024
Q4 		$361K Hold
34,069
– – ﹤0.01% 1201
2024
Q3 		$828K Hold
34,069
– – ﹤0.01% 1224
2024
Q2 		$961K Hold
34,069
– – ﹤0.01% 1169
2024
Q1 		$1.39M Hold
34,069
– – ﹤0.01% 1110
2023
Q4 		$562K Sell
34,069
-6,591
-16% -$115K ﹤0.01% 1284
2023
Q3 		$1.54M Buy
40,660
+17,034
+72% +$807K ﹤0.01% 1033
2023
Q2 		$1.3M Buy
23,626
+480
+2% +$22K ﹤0.01% 1071
2023
Q1 		$995K Hold
23,146
– – ﹤0.01% 1135
2022
Q4 		$910K Hold
23,146
– – ﹤0.01% 1157
2022
Q3 		$1.18M Buy
23,146
+2,150
+10% +$134K ﹤0.01% 1146
2022
Q2 		$1.38M Hold
20,996
– – ﹤0.01% 1114
2022
Q1 		$1.54M Sell
20,996
-2,766
-12% -$160K ﹤0.01% 1161
2021
Q4 		$1.68M Buy
23,762
+4,828
+25% +$843K ﹤0.01% 1174
2021
Q3 		$4.75M Buy
18,934
+1,142
+6% +$273K ﹤0.01% 833
2021
Q2 		$3.87M Buy
17,792
+2,048
+13% +$613K ﹤0.01% 903
2021
Q1 		$4.48M Buy
15,744
+4,956
+46% +$1.59M 0.01% 860
2020
Q4 		$3.06M Buy
10,788
+8,206
+318% +$2.63M ﹤0.01% 909
2020
Q3 		$798K Buy
2,582
+230
+10% +$55K ﹤0.01% 1127
2020
Q2 		$494K Buy
+2,352
New +$524K ﹤0.01% 1215

Other funds holding GBIO

ACM
Accent Capital Management Centerville, Ohio $231M AUM 33.86% 1-Year Est. Return

TD Asset Management's GBIO Position: Q1 2026 in Review

TD Asset Management sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 26,708 shares — an estimated $152K sold.

TD Asset Management first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $4.75M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

  • TD Asset Management reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
  • TD Asset Management sold 26,708 Generation Bio shares in Q1 2026, an estimated $152K.
  • TD Asset Management first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
  • TD Asset Management's Generation Bio position peaked at $4.75M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.